Decision Diagnostics

Decision Diagnostics EBIT par action

EBIT par action de Decision Diagnostics (DECN) au 24 oct. 2026 est -0,01 USD. L'année précédente, EBIT par action était -0,01 USD — une variation de -10,22 % (plus élevé).

EBIT par action

-0,01USD

YoY

-10,22%

Dernière mise à jour:

EBIT par action de Decision Diagnostics est 2020 -0,01 USD. EBIT par action de Decision Diagnostics était 2019 -0,01 USD. Elle diminue ainsi de -10,22% plus élevé par rapport à l'année précédente.

Accéder à ces données via l’API Eulerpool

100 000 requêtes/mois gratuites · sans carte bancaire

Decision Diagnostics Analyse d'actions

Que fait Decision Diagnostics ? The Decision Diagnostics Corp, founded in 2002, is a company specializing in the manufacturing of medical diagnostic test kits and devices. The company is headquartered in Westlake Village, California, and operates production facilities in various parts of the world. The company's history began when the founders recognized a need for reliable, affordable, and easy-to-use diagnostic devices. This realization led to the development of the first product, the Shasta GenStrip. This test strip allowed patients to monitor their blood sugar levels at home, thereby better managing their diabetes. Since then, Decision Diagnostics Corp has become a leading provider of diagnostic test kits and devices. The company has several divisions, including the pharmaceutical division, the medical division, and the consumables division. In the pharmaceutical division, the company develops and produces tests for the pharmaceutical industry. These tests are used to assess the efficacy of new drugs and detect side effects. The medical division, on the other hand, focuses on developing diagnostic devices for various applications. This includes a test for detecting cancer markers in the blood or a test for assessing vitamin D levels. Another important division of the company is the consumables division. Here, the company provides test strips, syringes, needles, and other materials needed in medical practices and hospitals. The business model of Decision Diagnostics Corp is based on the idea that every person has the right to reliable medical care. Therefore, the company is committed to developing diagnostic devices and test kits that are easy to use and affordable. This allows patients to independently monitor their condition at home and take quick action if necessary. An example of this is the Shasta GenStrip, the first test strip developed by the company. This test strip allows patients to measure their blood sugar at home and better manage their diabetes. The Shasta GenStrip is compatible with common blood glucose meters and is significantly cheaper than comparable products. Another product developed in the medical division is the eScreen. This device allows for quick and reliable testing of urine samples for drugs or alcohol. The eScreen is primarily used in occupational medicine to ensure that employees are not using drugs. Overall, Decision Diagnostics Corp has become an important player in the medical industry. The company strives to provide patients with access to high-quality and affordable diagnostic devices and test kits. Through the constant development of innovative products, the company contributes to improving medical care worldwide. Decision Diagnostics est l'une des entreprises les plus populaires sur Eulerpool.

Questions fréquemment posées sur l'action Decision Diagnostics

EBIT par action de Decision Diagnostics s'élève à -0,01 USD en 2020.

EBIT par action de Decision Diagnostics a changé de -0,01 USD à -0,01 USD, ce qui représente une variation de -10,22 %. La valeur est plus élevé qu'l'année précédente.

Sur Eulerpool, vous trouverez l'évolution historique complète de Decision Diagnostics de EBIT par action depuis 2006 – avec des valeurs annuelles, des graphiques et une analyse détaillée.

L'EBIT par action mesure le bénéfice opérationnel attribué à chaque action en circulation.

Accéder à ces données via l’API Eulerpool

100 000 requêtes/mois gratuites · sans carte bancaire

Compte de résultat — Decision Diagnostics

Toutes les Métriques Clés — Decision Diagnostics

Croissance